Research from NeuroQure, a biotechnology company specializing in autism spectrum disorder, has led to the development of a skin punch biopsy that can be used as early as the second day after birth to ...
Consultant Fee/Honoraria/Speaker's Bureau - Abbott Vascular; Siemens Healthineers Institutional Grant Support - Edwards Lifesciences; Medtronic Grant Support/Research Contract - JenaValve Receive the ...
The Supreme Court on Friday said stem cell therapies for Autism Spectrum Disorder ASD cannot be offered by medical practitioners as a clinical service outside an approved and monitored clinical trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results